...
首页> 外文期刊>Hepato-gastroenterology. >Lipiodol accumulation and transarterial chemoembolization efficacy for HCC patients
【24h】

Lipiodol accumulation and transarterial chemoembolization efficacy for HCC patients

机译:肝癌患者的碘油积累和经动脉化学栓塞疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: To elucidate the prognostic factors for hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE). Methodology: We studied 85 TACE-treated HCC patients, including 117 lesions, who fulfilled the Milan criteria. The area of iodized poppy-seed oil (lipiodol) accumulation on CT immediately after TACE was classified into three groups, by comparing with the area of HCC detected by CT during hepatic arteriography; accumulation surrounding the HCC lesion (group I), accumulation involving the entire area of the HCC lesion (group II), and accu-mulation that covered a portion of the HCC lesion (group III). Results: Among 85 patients, the 1- and 2-year disease free survival (DFS) rates were 67% and 50% in group I, 49% and 29% in group II and 29% and 15% in group III. DFS rate was higher in group I than in groups II and III (p=0.016 and p<0.001). Difference in DFS by lipiodol accumulation pattern was evident in patients aged 75 or younger. Conclusions: Lipiodol accumulation pattern as evaluated by CT immediately after TACE may be a powerful indicator of the therapeutic efficacy of TACE in HCC patients.
机译:背景/目的:阐明经动脉化疗栓塞(TACE)治疗的肝细胞癌(HCC)患者的预后因素。方法:我们研究了85例符合米兰标准的TACE治疗的HCC患者,包括117个病变。通过与肝动脉造影中CT检测到的HCC面积进行比较,将TACE后立即在CT上碘化的罂粟籽油(碘油)积聚的区域分为三类。肝癌病变周围的积聚(I组),涉及肝癌病变整个区域的积聚(II组)以及覆盖肝癌病变一部分的积聚(III组)。结果:在85例患者中,I组的1年和2年无病生存率(DFS)分别为67%和50%,II组为49%和29%,III组为29%和15%。 I组的DFS率高于II组和III组(p = 0.016和p <0.001)。在75岁以下的患者中,通过碘油积累模式的DFS差异明显。结论:TACE治疗后立即通过CT评估的碘油积累模式可能是TACE治疗肝癌的有效指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号